fashion -WSS

fashion

author：leisure time 2025-10-02 04:07:29 - browse：1969

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Biden administration begins canceling student loan debt for 804,000 borrowers

leisure time

focus

WSS

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Sweden knocks USA out of World Cup in penalty kicks

Bird flu researchers hone in on Finland’s mink farms

Megan Rapinoe shares emotional post following US Women's World Cup exit

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

explore

fashion

hotspot

Drug repurposing or repositioning? The language matters

Hospitals are dialing back on venture capital investing

New air purifier tech could be key to improving indoor air quality

Paxlovid rebound happens. Why and to whom are still a mystery

Trump demands the U.S. pay no more for drugs than other countries … again

Surge in Apellis stock fueled by confidence in safety of its eye drug

United colonoscopy coverage change 'may cost lives,' doctors say

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Medicare details structure of new drug price negotiation program

Tuberculosis patients need more than just free medication

hotspot

With heat waves through August, officials warn of health risks

YouTube cracks down on misinformation on cancer treatment

After Optum profits sink, UnitedHealth makes changes

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

Bird flu researchers hone in on Finland’s mink farms

It was time to plan for my old age. If only I could stop crying

leisure time

leisure time

focus

entertainment